Menu

An innovative non-opioid treatment option

SCS is engineered to relieve chronic pain.

Spinal cord stimulation delivers small electrical pulses that disrupt pain signals before they reach the brain, offering relief. Studies suggest spinal cord stimulation may offer:

  • Long-term pain relief1–3
  • Improved quality of life1,2
  • More efficacy than repeat surgery for persistent radicular pain after lumbosacral spine surgery4
  • Successful pain disability reduction2
  • Cost savings compared to conventional medical management and reoperation3–5
  • Potential reduction in oral opioid consumption6–8

Access on-demand education and training materials.

Visit Medtronic Academy (open in new window)
The Inceptiv™ neurostimulator uses closed-loop technology helps relieve chronic pain.

Transforming SCS through sensing†

Meet the Inceptiv™ SCS device, the most advanced system with closed-loop technology.

Providing patients with:

  • Automatic closed-loop, which senses† and responds to deliver consistent therapy
  • Best full-body 1.5T and 3T MRI Conditional access with impedance independence
  • Smallest and thinnest implantable SCS device, designed for comfort
Discover Inceptiv™ SCS
A female healthcare professional looks at a tablet while speaking with a patient.

Multiple treatment indications

Medtronic SCS is indicated for chronic back pain, chronic upper limb pain, and leg and foot pain caused by diabetic peripheral neuropathy (DPN).

View approved conditions
Two Healthcare professionals looking at laptop

Years of clinical outcomes

Differential Target Mutiplexed™ SCS programming, proven on Intellis™ SCS system and now available on Inceptiv™, demonstrated a 83.7% 12-month back pain responder rate with open-loop stimulation.9

See the data

Featured products

† Sensing signals may not be measurable in all cases.

  1. Kumar K, Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63(4):762–770;discussion 770.
  2. Harke H, Gretenkort P, Ladleif HU, Rahman S. Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical study. Eur J Pain. 2005:9(4);363–373.
  3. Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg. 2008;108(2):292–298.
  4. North RB, Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery. 2005;56(1):98–107.
  5. Taylor RJ, Taylor, RS. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effective analysis. Int J Technol Assess Health Care. 2005;21(3):351–358.
  6. Gee L, Smith HC, Ghulam-Jelani Z, et al. Spinal cord stimulation for the treatment of chronic pain reduces opioid use and results in superior clinical outcomes when used without opioids. Neurosurgery. 2019;84(1):217–226. A nonrandomized prospective cohort study of SCS patients between September 2012 and August 2015 (N=86 [n=53 on opioids]).
  7. Sharan AD, Riley J, Falowski S, et al. Association of opioid usage with spinal cord stimulation outcomes. Pain Med. 2018 Apr 1;19(4):699–707. A non-randomized analysis of Truven Health Marketscan databases from January 2010 to December 2014 based on the first occurrence of an SCS implant (N= 5,476).
  8. Pollard EM, Lamer TJ, Moeschler SM, et al. The effect of spinal cord stimulation on pain medication reduction in intractable spine and limb pain: a systematic review of randomized controlled trials and meta-analysis. Pain Res. 2019:12:1311–1324. A research review summarizing SCS studies with respect to opioid use and a further meta-analysis of comparative SCS RCTs of 1 year or greater duration (N=489).
  9. Fishman et al, Twelve-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 21(8):912–923.